MAKE BETTER DECISIONS Join the 500+ leading biopharmaceutical companies we have served and make better decisions with DrugPatentWatch’s deep knowledge on biologic and small molecule drugs. Check out our flexible…
The post Make Better Decisions With Dru…
Get Customized Access to DrugPatentWatch’s Rich Database DrugPatentWatch provides deep actionable business intelligence on small-molecule drugs and the 1.3 million global patents and applications covering them. DrugPatentWatch was founded in̷…
Integrate DrugPatentWatch Into Your Application or Data Store Read Post »
A guide for portfolio managers, business analysts, formulary directors, and more… Navigating the myriad service providers for biopharmaceutical business intelligence can be daunting. Just like a Swiss Army knife, many…
The post What are the top B…
What are the top Biopharmaceutical Business Intelligence Services? Read Post »
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
Patenting the Microbiome – Part 2: Microbiome IP Panel, 2017 BIO Convention Read Post »
Get Customized Access to DrugPatentWatch’s Rich Database DrugPatentWatch provides deep actionable business intelligence on small-molecule drugs and the 1.3 million
Integrate DrugPatentWatch Into Your Application or Data Store Read Post »
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
After months of development and feedback from customers, DrugPatentWatch is proud to announce the availability of two new datasets: Bulk
New features from DrugPatentWatch – Bulk API sources and clinical trials Read Post »
Share your expertise with our expansive network > Go to submission form
Approved Drug Products With Therapeutic Equivalance Evaluations In addition to its deep database of global drug and patent information, DrugPatentWatch
I have a tool that can be used to measure the impact of Brexit on biotechnology in the United Kingdom.